Case Report
Published on 08 Jan 2026
Sequential anlotinib and camrelizumab combination therapy achieves exceptional survival in multi-driver mutated, TMB-low/PD-L1-low/MSS pulmonary sarcomatoid carcinoma: case report and literature review
in Cancer Immunity and Immunotherapy
- 890 views